Ahsan Z Rizvi

Years Active: 2019-2019
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean-Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Braye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary, Eric Angevin, Alexander M Eggermont, Fabrice Andre, Christophe Massard, Ken A Olaussen, Jean-Charles Soria, Benjamin Besse, Luc Friboulet
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)

Ahsan Z Rizvi.css-eqlu8i{font-size:small;padding-left:4px;}